These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7405968)

  • 1. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Can Anaesth Soc J; 1984 Jan; 31(1):80-2. PubMed ID: 6581851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal prostaglandin E2 for missed abortion and intrauterine fetal death.
    Rutland A; Ballard C
    Am J Obstet Gynecol; 1977 Jul; 128(5):503-6. PubMed ID: 879208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of uterine activity after vaginal administration of prostaglandins.
    Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
    Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical ripening with prostaglandin E2 vaginal suppositories.
    Buchanan D; Macer J; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):659-63. PubMed ID: 6585733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone changes in relation to the time of fetal death after prostaglandin-induced abortion.
    Fraser IS; Nicholson KM; Graham G; Boyle H
    Prostaglandins; 1977 Jun; 13(6):1161-7. PubMed ID: 887804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.